To the Editor: Recent legislation mandates active surveillance cultures to detect multidrug-resistant (MDR) organisms in hospitalized patients. 1 The active surveillance strategy has not been widely applied to MDR Acinetobacter, one of the most difficult gram-negative pathogens to control and treat.
A significantly higher proportion of patients with MDR Acinetobacter were admitted from a long-term care facility than patients without MDR Acinetobacter (46.2% vs 3.9%; risk ratio, 18.9; 95% CI, 6.6-54) (TABLE 2). Patients with MDR Acinetobacter were more likely to have paraplegia than were patients without MDR Acinetobacter (23.1% vs 1.1%; risk ratio, 22; 95% CI, 6.7-72). The majority of patients with MDR Acinetobacter were co-colonized with at least 1 other MDR pathogen: methicillin-resistant Staphylococcus aureus (n=8, 62%), vancomycin-resistant Enterococci (n=10, 77%), and extended-spectrum ␤-lactamase gram-negative bacilli (n=5, 38%).
Comment. The potential consequences of MDR Acinetobacter transmission and infection include a crude mortality of 28% to 58%, prolonged mechanical ventilation, and prolonged stays in the hospital and intensive care unit. 4, 5 In this cohort, most MDR Acinetobacter was present on hospital admission and the undetected fraction of MDR Acinetobacter was 50%. Limitations include low sensitivity of MDR Acinetobacter surveillance cultures, 6 small sample size of patients with MDR Acinetobacter, absent admission surveillance cultures, few wound and endotracheal cultures, and generalizability to other health care settings.
Although active surveillance cultures may be indicated during an outbreak, in general a population at risk should be defined before beginning an active surveillance program to detect MDR organisms. Although universal active surveillance cultures identified otherwise undetected patients with MDR Acinetobacter, screening all admissions required 
